ghk cu peptide bodybuilding What Is GHK-Cu Copper Peptide? How It Works + Real User Results GHK-Cu (Copper Peptide) - Research

Selected Clinical Trial Activity BPC-157 + TB-500 is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development

Product Specifications Dosage (Male) 200-500mcg per day Dosage (Female) 200-500mcg per day Anabolic Rating N/A Androgenic Rating N/A Active Half-Life Approximately 24 hours Chemical Name Gly-Glu-Pro-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Stack With

BPC 157 entered early-phase clinical development for inflammatory bowel disease as PL 14736 (Pliva, Croatia), and a 2025 pilot examined intravenous administration in a small cohort, but no adequately powered randomised controlled trial exists

Diab 6 , 394402 (2014)

Lluch, J

What they found: Mean weight loss: 2.6 kg vs 2.3 kg placebo , a difference of only 0.3 kg (1 %) Statistically non-significant Clinically unsatisfactory for the obesity indication Safety profile remained favorable Why it matters: The study stopped the development of AOD-9604 as a drug